Ahmad B, Asif M, Ali A, Jamal S, Khan MZ, Khadim MT (2020) Expression of Ki-67 and βeta-catenin in pseudoepitheliomatous hyperplasia and squamous cell carcinoma in oral mucosal biopsies: an immunohistochemical study. Asian Pac J Cancer Prev 21(1):157–161
Babiuch K, Kuśnierz-Cabala B, Kęsek B, Okoń K, Darczuk D, Chomyszyn-Gajewska M (2020) Evaluation of proinflammatory, NF-kappaB dependent cytokines: IL-1α, IL-6, IL-8, and TNF-α in tissue specimens and saliva of patients with oral squamous cell carcinoma and oral potentially malignant disorders. J Clin Med 9(3):867
Bandhakavi S, Van Riper S, Tawfik P, Stone M, Haddad T, Rhodus N, Carlis J, Griffin T (2011) Hexapeptide libraries for enhanced protein PTM identification and relative abundance profiling in whole human saliva. J Proteome Res 10(3):1052–1061
Beevi BH, Nayak SR, Peter CD, Haridas AK, Jacob L, Aboobakker A (2019) Analysis of Ki-67 expression in oral premalignant lesions and normal oral mucosa: an immunohistochemical study. J Pharm Bioallied Sci 11(Suppl 2):S232–S235
Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A, Balija M (2012) Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal 17(1):e10–e15
Chen FC, Zhang F, Zhang ZJ, Meng SY, Wang Y, Xiang XR, Wang C, Tang YY (2013) Tumor necrosis factor-α gene polymorphisms and risk of oral cancer: evidence from a meta-analysis. Asian Pac J Cancer Prev 14(12):7243–7249
Cheng K, Zhao YJ, Liu L, Wan JJ (2013) Tumor necrosis factor-α 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis. Asian Pac J Cancer Prev 14(5):3275–3279
Dadfarnia T, Mohammed BS, Eltorky MA (2012) Significance of Ki-67 and p53 immunoexpression in the differential diagnosis of oral necrotizing sialometaplasia and squamous cell carcinoma. Ann Diagn Pathol 16(3):171–176
Dash KC, Mahapatra N, Bhuyan L, Panda A, Behura SS, Mishra P (2020) An immunohistochemical study showing Ki-67 as an analytical marker in oral malignant and premalignant lesions. J Pharm Bioallied Sci 12(Suppl 1):S274–S278
Deepthi G, Nandan SRK, Kulkarni PG (2019) Salivary tumour necrosis factor-α as a biomarker in oral leukoplakia and oral squamous cell carcinoma. Asian Pac J Cancer Prev 20(7):2087–2093
Dragomir LP, Simionescu C, Mărgăritescu C, Stepan A, Dragomir IM, Popescu MR (2012) P53, p16 and Ki67 immunoexpression in oral squamous carcinomas. Rom J Morphol Embryol 53(1):89–93
Juretić M, Cerović R, Belušić-Gobić M, Brekalo Pršo I, Kqiku L, Špalj S, Pezelj-Ribarić S (2013) Salivary levels of TNF-α and IL-6 in patients with oral premalignant and malignant lesions. Folia Biol (praha) 59(2):99–102
Kaur J, Jacobs R (2015) Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis. J Korean Assoc Oral Maxillofac Surg 41(4):171–175
Koontongkaew S (2013) The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer 4(1):66–83
Korostoff A, Reder L, Masood R, Sinha UK (2011) The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral Oncol 47(4):282–287
Krishnan R, Thayalan DK, Padmanaban R, Ramadas R, Annasamy RK, Anandan N (2014) Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease. Asian Pac J Cancer Prev 15(17):7141–7148
Langer CJ (2012) Exploring biomarkers in head and neck cancer. Cancer 118(16):3882–3892
Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11(1):9–22
Li LT, Jiang G, Chen Q, Zheng JN (2015) Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol Med Rep 11(3):1566–1572
Lingen MW, Pinto A, Mendes RA, Franchini R, Czerninski R, Tilakaratne WM, Partridge M, Peterson DE, Woo SB (2011) Genetics/epigenetics of oral premalignancy: current status and future research. Oral Dis 17(Suppl 1):7–22
Liu J, Duan Y (2012) Saliva: a potential media for disease diagnostics and monitoring. Oral Oncol 48(7):569–577
Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT, Tang GY (2010) Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer 10:685
Liu D, Zhao X, Zeng X, Dan H, Chen Q (2016) Non-invasive techniques for detection and diagnosis of oral potentially malignant disorders. Tohoku J Exp Med 238(2):165–177
Mehrotra R, Gupta DK (2011) Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol 28:3–33
Mercadante V, Paderni C, Campisi G (2012) Novel non-invasive adjunctive techniques for early oral cancer diagnosis and oral lesions examination. Curr Pharm Des 18(34):5442–5451
Messadi DV (2013) Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci 5(2):59–65
Pesce MA, Spitalnik SL (2007) Saliva and the clinical pathology laboratory. Ann N Y Acad Sci 1098:192–199
Polz-Dacewicz M, Strycharz-Dudziak M, Dworzański J, Stec A, Kocot J (2016) Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections. Infect Agent Cancer 20(11):45
Prasad G, McCullough M (2013) Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer. Int J Dent 2013:813756. https://doi.org/10.1155/2013/813756
Qin Y, Zhong Y, Zhu M, Dang L, Yu H, Chen Z, Chen W, Wang X, Zhang H, Li Z (2013) Age- and sex-associated differences in the glycopatterns of human salivary glycoproteins and their roles against influenza A virus. J Proteome Res 12(6):2742–2754
Ragab H, Samy N, Afify M, Abd-El-Maksoud N, Shaaban H (2018) Assessment of Ki-67 as a potential biomarker in patients with breast cancer. J. Gene. Eng. Biotech. 16(2):479–484
Raju B, Mehrotra R, Oijordsbakken G, Al-Sharabi AK, Vasstrand EN, Ibrahim SO (2005) Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters. Anticancer Res 25(6C):4699–4706
Rezazadeh F, Ebrahimi R, Andisheh-Tadbir A, Ashraf MJ, Khademi B (2017) Evaluation of the Ki-67 and MCM3 expression in cytologic smear of oral squamous cell carcinoma. J Dent (shiraz) 18(3):207–211
Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F (2005a) NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 29(1):42–45
Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F (2005b) The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 44(2):77–82
SahebJamee M, Eslami M, AtarbashiMoghadam F, Sarafnejad A (2008) Salivary concentration of TNFalpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 13(5):E292–E295
Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I, Gavish M, Nagler RM (2009) Salivary analysis of oral cancer biomarkers. Br J Cancer 101(7):1194–1198
Triani M, Widodo HB, Novrial D, Agustina D, Nawangtantrini G (2021) Salivary ki-67 and micronucleus assay as potential biomarker of OSCC in betel nut chewers. J Indian Acad Oral Med Radiol 33:146–151
Van der Waal I (2009) Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45(4–5):317–323
Warnakulasuriya S, Ariyawardana A (2016) Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med 45(3):155–166
Warnakulasuriya S, Johnson NW, van der Waal I (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36(10):575–580
Yang EC, Tan MT, Schwarz RA, Richards-Kortum RR, Gillenwater AM, Vigneswaran N (2018) Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions. Oral Surg Oral Med Oral Pathol Oral Radiol 125(6):670–681
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.springeropen.com/)
